Stock screener

TECX

Conviction 27HealthcareScan · Thu, Sep 24, 2026

Tectonic Therapeutic, Inc. (TECX) closed at $24.01 (-3.88%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 28, RS Rating 84, -36.7% from its 52-week high, +14.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

TECX$24.01-3.88%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 186.32K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Tectonic Therapeutic, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tectonictx.com ↗
Price24.01
Change-3.88%
Gap-1.40%
Rel volume0.90×
Avg volume215.63K
Avg $ vol6.33M
SMA 2029.28
SMA 5031.24
SMA 20027.87
Price vs 50-23.15%
Price vs 200-13.85%
MA stackmixed
50/200 cross—
Supertrenddown · 29.78
RSI (14)28
MACD hist-0.54
MACD cross—
Stoch %K / %D9 / 8
ADX (14)30
+DI / −DI11 / 31
RSI divergenceBearish
MACD divergenceBearish
ATR %8.01%
ADR %6.79%
52w high37.93
52w low14.71
From 52w high-36.70%
Above 52w low+63.22%
New 52w highNo
SqueezeOff
Bollinger width40.94%
%B0.06
Donchian pos5.12%
Donchian high38.00
Donchian low23.26
AVWAP (52w high)32.25
vs AVWAP high-25.54%
AVWAP (52w low)23.89
vs AVWAP low+0.50%
OBV trendDown
Chaikin MF (20)-0.38
Today vs 20d0.90×
Avg vol (14d)186.32K
Avg vol (20d)215.63K
Avg $ vol (20d)6.33M
Market cap469.38M
RS Rating84 / 99
RS 3m (vs SPY)-27.11%
RS 6m (vs SPY)-39.52%
RS line new highNo
Trend template4/8
Technical rank13.1
1 week-11.76%
1 month-36.33%
3 months-22.62%
6 months-22.70%
1 year+58.90%
YTD+14.83%
P/E-6.33
P/B2.10
P/S—
P/FCF-7.79
EPS-4.05
Div yield—
ROE-33.13%
ROA-31.28%
Debt/Eq0.07
Current22.29
EV/EBITDA-3.11
Gross margin—
Net margin—
Rev growth—
EPS growth-27.89%
Price target78.67
Target upside227.66%
Analyst ratingBuy
Institutional75.04%
Ent. value257.31M
Revenue—
Net income-22.29M
Gross profit—
Free cash flow-60.29M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out18.87M
Employees60
ListedFri, Jun 21, 2024
Free float9.88M
Float %52.6%
Short interest1.94M
Days to cover7.6d
Short volume56.6%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.18 vs −$1.41
Last surprise+16.3% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank13.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance38.12
Support28.68
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TECX

All disclosures →
No recent disclosed trades by Congress in TECX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TECX · open-market 2 sells

InsiderSideShares
McNamara Peter
Chief Scientific Officer · Common Stock · 2026-08-25
Exercise43
McNamara Peter
Chief Scientific Officer · Common Stock · 2026-08-25
Sell43
McNamara Peter
Chief Scientific Officer · Employee Stock Option (Right to Buy) · 2026-08-25
Exercise43
McNamara Peter
Chief Scientific Officer · Common Stock · 2026-08-12
Exercise43
McNamara Peter
Chief Scientific Officer · Common Stock · 2026-08-12
Sell43
McNamara Peter
Chief Scientific Officer · Employee Stock Option (Right to Buy) · 2026-08-12
Exercise43
Vitorovic Stefan
Director · Stock Option (Right to Buy) · 2026-06-09
Grant10.2K
Donenberg Phillip B.
Director · Stock Option (Right to Buy) · 2026-06-09
Grant10.2K
Tipirneni Praveen P.
Director · Stock Option (Right to Buy) · 2026-06-09
Grant10.2K
SPRINGER TIMOTHY A
Director · Stock Option (Right to Buy) · 2026-06-09
Grant10.2K

SEC filings

EDGAR filings in TECX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.